Table 5.
Clinical characteristics, tools, and outcomes of patients with a damaged lead during LBBAP lead implant
| Age (y) | Sex | Pacing indication | Structural heart disease | IVS (mm) | Lead type | Sheath | Lead model | Outcome | Clinical consequences | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 85 | M | AV block | Valvular, TAVR | 15.7 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with second Solia lead | No |
| 2 | 71 | F | AV block | No | 12 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with 3830 | Severe TR |
| 3 | 86 | M | AV block | No | 12 | SDL | SPCC 3 | Ingevity 7742-59 | LBBAP with 3830 | No |
| 4 | 79 | M | AV block | Valvular, TAVR | 10.5 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with 3830 | No |
| 5 | 81 | M | AV block | Valvular, TAVR | 14 | SDL | Selectra 3D 55-42 | Solia S60 | Conventional myocardial pacing with second Solia S60 lead | No |
| 6 | 83 | F | AV block | Valvular, TAVR | 14.4 | SDL | Selectra 3D 55-42 | Solia S60 | Conventional myocardial pacing with second Solia S60 lead | No |
| 7 | 73 | M | SSS | No | 10 | LLL | C315His | 3830-69 | LBBAP with second 3830 | No |
| 8 | 81 | M | AV block | No | 14 | LLL | C315His | 3830-69 | LBBAP with second 3830 | No |
| 9 | 75 | F | SSS | No | 8.9 | LLL | C315His | 3830-69 | LBBAP with second 3830 | No |
| 10 | 87 | F | AV block | CAD | 11 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with 3830 | No |
| 11 | 52 | M | AV block | NICM | 12 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with 3830 | No |
| 12 | 74 | M | AV block | CAD | 9.4 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with second Solia lead | No |
| 13 | 81 | F | AV block | CAD | 8.8 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with second Solia lead | No |
| 14 | 75 | F | SSS | No | 12 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with second Solia lead | No |
| 15 | 81 | M | SSS | CAD | 11 | SDL | Selectra 3D 55-42 | Solia S60 | LBBAP with second Solia lead | No |